(Total Views: 110)
Posted On: 04/03/2019 3:05:40 PM
Post# of 21202
$DMPI News Article - DelMar Pharmaceuticals Receives Approval from MD Anderson Cancer Center's IRB for Protocol Expansion to Include Maintenance Stage MGMT-unmethylated GBM Patients in Ongoing Phase 2 Trial of VAL-083 https://marketwirenews.com/news-releases/delm...38168.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
